PDC Drug Synthesis Services

As the global demand for targeted cancer therapy grows, PDC has emerged as a next-generation hot technology with its "small molecule flexibility + antibody-level precision." Motif continues to optimize the PDC technology platform, driving scientific advancements and process innovations. This enables it to provide PDC collaboration services to research institutions and pharmaceutical companies worldwide, offering efficient, safe, and customizable drug development solutions. The business covers solid tumors, hematological malignancies, and drug-resistant cancers, leading new trends in precision medicine and accelerating the rapid development and clinical application of innovative anti-cancer drugs.

We provide one-stop "peptide design-synthesis-coupling-characterization" service to support customers' personalized needs, such as fluorescence labeling, isotope labeling, etc., to meet the needs of different customers and promote the development and application of PDC drugs.

(1) Core technology advantages

(2) High standard synthesis process

(3) Quality control and analysis

(4) Clinical transformation advantages